{"id":"https://openalex.org/W1978628771","doi":"https://doi.org/10.1002/ajmg.b.30319","title":"Association between the DRD2 A1 allele and response to methadone and buprenorphine maintenance treatments","display_name":"Association between the DRD2 A1 allele and response to methadone and buprenorphine maintenance treatments","publication_year":2006,"publication_date":"2006-03-31","ids":{"openalex":"https://openalex.org/W1978628771","doi":"https://doi.org/10.1002/ajmg.b.30319","mag":"1978628771","pmid":"https://pubmed.ncbi.nlm.nih.gov/16583408"},"language":"en","primary_location":{"id":"doi:10.1002/ajmg.b.30319","doi":"https://doi.org/10.1002/ajmg.b.30319","is_oa":false,"landing_page_url":"https://doi.org/10.1002/ajmg.b.30319","pdf_url":null,"source":{"id":"https://openalex.org/S2764647521","display_name":"American Journal of Medical Genetics Part B Neuropsychiatric Genetics","issn_l":"1552-4841","issn":["1552-4841","1552-485X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Medical Genetics Part B: Neuropsychiatric Genetics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077900083","display_name":"Daniel Thomas Barratt","orcid":"https://orcid.org/0000-0001-6261-353X","observed_orcids":["https://orcid.org/0000-0001-6261-353X"]},"institutions":[{"id":"https://openalex.org/I5681781","display_name":"The University of Adelaide","ror":"https://ror.org/00892tw58","country_code":"AU","type":"education","lineage":["https://openalex.org/I4405259444","https://openalex.org/I5681781"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Daniel T. Barratt","raw_affiliation_strings":["Discipline of Pharmacology, School of Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia. daniel.barratt@adelaide.edu.au","Discipline of Pharmacology School of Medical Sciences University of Adelaide Adelaide South Australia Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discipline of Pharmacology, School of Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia. daniel.barratt@adelaide.edu.au","institution_ids":["https://openalex.org/I5681781"]},{"raw_affiliation_string":"Discipline of Pharmacology School of Medical Sciences University of Adelaide Adelaide South Australia Australia","institution_ids":["https://openalex.org/I5681781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046046009","display_name":"Janet K. Coller","orcid":"https://orcid.org/0000-0002-8273-5048","observed_orcids":["https://orcid.org/0000-0002-8273-5048"]},"institutions":[{"id":"https://openalex.org/I5681781","display_name":"The University of Adelaide","ror":"https://ror.org/00892tw58","country_code":"AU","type":"education","lineage":["https://openalex.org/I4405259444","https://openalex.org/I5681781"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Janet K. Coller","raw_affiliation_strings":["Discipline of Pharmacology, School of Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discipline of Pharmacology, School of Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia","institution_ids":["https://openalex.org/I5681781"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089827696","display_name":"Andrew Alexander Somogyi","orcid":"https://orcid.org/0000-0003-4779-0380","observed_orcids":["https://orcid.org/0000-0003-4779-0380"]},"institutions":[{"id":"https://openalex.org/I1320133117","display_name":"Royal Adelaide Hospital","ror":"https://ror.org/00carf720","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1320133117","https://openalex.org/I4392738059"]},{"id":"https://openalex.org/I5681781","display_name":"The University of Adelaide","ror":"https://ror.org/00892tw58","country_code":"AU","type":"education","lineage":["https://openalex.org/I4405259444","https://openalex.org/I5681781"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Andrew A. Somogyi","raw_affiliation_strings":["Department of Clinical Pharmacology, Royal Adelaide Hospital, Adelaide, South Australia, Australia","Discipline of Pharmacology, School of Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, Royal Adelaide Hospital, Adelaide, South Australia, Australia","institution_ids":["https://openalex.org/I1320133117"]},{"raw_affiliation_string":"Discipline of Pharmacology, School of Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia","institution_ids":["https://openalex.org/I5681781"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5077900083"],"corresponding_institution_ids":["https://openalex.org/I5681781"],"apc_list":{"value":3920,"currency":"USD","value_usd":3920},"apc_paid":null,"fwci":2.7864,"has_fulltext":false,"cited_by_count":94,"citation_normalized_percentile":{"value":0.89344819,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"141B","issue":"4","first_page":"323","last_page":"331"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.011599999852478504,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dopamine-d2-receptor-gene","display_name":"dopamine D2 receptor gene","score":0.9649999737739563},{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.7089999914169312},{"id":"https://openalex.org/keywords/methadone-maintenance-treatment","display_name":"methadone maintenance treatment","score":0.9399999976158142},{"id":"https://openalex.org/keywords/buprenorphine-maintenance-treatment","display_name":"buprenorphine maintenance treatment","score":0.984000027179718},{"id":"https://openalex.org/keywords/heroin-use","display_name":"heroin use","score":0.9070000052452087},{"id":"https://openalex.org/keywords/opioid-withdrawal","display_name":"opioid withdrawal","score":0.7770000100135803}],"concepts":[{"id":"https://openalex.org/C2778949969","wikidata":"https://www.wikidata.org/wiki/Q407721","display_name":"Buprenorphine","level":4,"score":0.8222086429595947},{"id":"https://openalex.org/C2778767360","wikidata":"https://www.wikidata.org/wiki/Q179996","display_name":"Methadone","level":2,"score":0.788059413433075},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.6446782946586609},{"id":"https://openalex.org/C2778903686","wikidata":"https://www.wikidata.org/wiki/Q60168","display_name":"Heroin","level":3,"score":0.6112772822380066},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6032066345214844},{"id":"https://openalex.org/C135763542","wikidata":"https://www.wikidata.org/wiki/Q106016","display_name":"Genotype","level":3,"score":0.5791645050048828},{"id":"https://openalex.org/C180754005","wikidata":"https://www.wikidata.org/wiki/Q80726","display_name":"Allele","level":3,"score":0.5787534713745117},{"id":"https://openalex.org/C2778903061","wikidata":"https://www.wikidata.org/wiki/Q17156814","display_name":"Methadone maintenance","level":3,"score":0.5498828291893005},{"id":"https://openalex.org/C55775858","wikidata":"https://www.wikidata.org/wiki/Q1152227","display_name":"Pharmacogenetics","level":4,"score":0.4707513451576233},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4618609845638275},{"id":"https://openalex.org/C2779418921","wikidata":"https://www.wikidata.org/wiki/Q1639178","display_name":"Opioid use disorder","level":4,"score":0.4305883049964905},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3940611481666565},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3251394033432007},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.17251765727996826},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.15644678473472595},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.15525087714195251},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.10560762882232666},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.10518601536750793}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000483","descriptor_name":"Alleles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000701","descriptor_name":"Analgesics, Opioid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002047","descriptor_name":"Buprenorphine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005787","descriptor_name":"Gene Frequency","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005838","descriptor_name":"Genotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006556","descriptor_name":"Heroin Dependence","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D006556","descriptor_name":"Heroin Dependence","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D006556","descriptor_name":"Heroin Dependence","qualifier_ui":"Q000534","qualifier_name":"rehabilitation","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008691","descriptor_name":"Methadone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013375","descriptor_name":"Substance Withdrawal Syndrome","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015252","descriptor_name":"Deoxyribonucleases, Type II Site-Specific","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017448","descriptor_name":"Receptors, Dopamine D2","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D017448","descriptor_name":"Receptors, Dopamine D2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1002/ajmg.b.30319","doi":"https://doi.org/10.1002/ajmg.b.30319","is_oa":false,"landing_page_url":"https://doi.org/10.1002/ajmg.b.30319","pdf_url":null,"source":{"id":"https://openalex.org/S2764647521","display_name":"American Journal of Medical Genetics Part B Neuropsychiatric Genetics","issn_l":"1552-4841","issn":["1552-4841","1552-485X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Medical Genetics Part B: Neuropsychiatric Genetics","raw_type":"journal-article"},{"id":"pmid:16583408","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16583408","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","raw_type":"Journal Article"},{"id":"pmh:oai:digital.library.adelaide.edu.au:2440/22792","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2440/22792","pdf_url":null,"source":{"id":"https://openalex.org/S4306401835","display_name":"Adelaide Research & Scholarship (AR&S) (University of Adelaide)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I5681781","host_organization_name":"The University of Adelaide","host_organization_lineage":["https://openalex.org/I5681781"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www3.interscience.wiley.com/cgi-bin/jissue/112634219","raw_type":"Journal article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G2862344485","display_name":"PAIN ANALGESIC RESPONSE IN OPIATE DEPENDENCE","funder_award_id":"R01DA013706","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G3093288203","display_name":null,"funder_award_id":"R01 DA13706-02","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"}],"funders":[{"id":"https://openalex.org/F4320334705","display_name":"National Health and Medical Research Council","ror":"https://ror.org/011kf5r70"},{"id":"https://openalex.org/F4320334737","display_name":"National Medical Research Council","ror":"https://ror.org/04x3cxs03"},{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W51644452","https://openalex.org/W84846239","https://openalex.org/W1500701263","https://openalex.org/W1817985333","https://openalex.org/W1964979617","https://openalex.org/W1971192317","https://openalex.org/W1978453350","https://openalex.org/W2000620904","https://openalex.org/W2001865657","https://openalex.org/W2004650335","https://openalex.org/W2004676994","https://openalex.org/W2011275122","https://openalex.org/W2017627129","https://openalex.org/W2023652011","https://openalex.org/W2024476680","https://openalex.org/W2030511384","https://openalex.org/W2031548893","https://openalex.org/W2047727407","https://openalex.org/W2049796382","https://openalex.org/W2063005726","https://openalex.org/W2065767068","https://openalex.org/W2068399246","https://openalex.org/W2075362165","https://openalex.org/W2085725480","https://openalex.org/W2088829922","https://openalex.org/W2092071349","https://openalex.org/W2098288561","https://openalex.org/W2106329966","https://openalex.org/W2109443151","https://openalex.org/W2135017718","https://openalex.org/W2139591064","https://openalex.org/W2142485125","https://openalex.org/W2146220657","https://openalex.org/W2165398609","https://openalex.org/W2169863475","https://openalex.org/W2170397982","https://openalex.org/W2338160022","https://openalex.org/W4240267522","https://openalex.org/W4246705708"],"related_works":["https://openalex.org/W2109443151","https://openalex.org/W2163149654","https://openalex.org/W2918773165","https://openalex.org/W2390711557","https://openalex.org/W3096716486","https://openalex.org/W2023090750","https://openalex.org/W986916444","https://openalex.org/W1893762565","https://openalex.org/W2997041140","https://openalex.org/W2367239075"],"abstract_inverted_index":{"The":[0,39],"TaqI":[1,80,88,167],"A":[2,81,168],"polymorphism":[3],"(A(1))":[4],"of":[5,17,27,41,53,221],"the":[6,78,179,198,211,219,222],"dopamine":[7],"D(2)":[8],"receptor":[9],"gene":[10],"(DRD2),":[11],"although":[12],"not":[13,203],"a":[14,50,214],"specific":[15],"predictor":[16],"opioid":[18,205,235],"dependence,":[19],"has":[20],"been":[21],"strongly":[22],"associated":[23],"with":[24],"high":[25],"levels":[26],"prior":[28,171],"heroin":[29,100,172,227],"use":[30,101,173,228],"and":[31,62,68,92,97,107,131,139,146,154,170,229],"poor":[32,140],"treatment":[33,105,141,207],"outcomes":[34],"among":[35,178],"methadone":[36,58,96,127,181],"maintenance":[37,206,232],"patients.":[38],"aims":[40],"this":[42],"study":[43],"were":[44,75,110,124,162],"to":[45,103,231],"confirm":[46],"these":[47],"findings":[48],"via":[49],"retrospective":[51],"analysis":[52],"A(1)":[54,120,185,224],"allele":[55,121,186,225],"frequency":[56,122],"in":[57,119,226],"(n":[59,64,71],"=":[60,65,72,150,158,175,194],"46)":[61],"buprenorphine":[63,98,129],"25)":[66],"patients,":[67],"non-opioid-dependent":[69],"controls":[70],"95).":[73],"Subjects":[74],"genotyped":[76],"at":[77],"DRD2":[79,199,223],"locus":[82],"using":[83],"PCR":[84],"amplification":[85],"followed":[86],"by":[87],"restriction":[89],"enzyme":[90],"digestion":[91],"gel":[93],"electrophoresis.":[94],"For":[95],"subjects,":[99,182],"(prior":[102],"treatment),":[104],"outcomes,":[106],"withdrawal":[108,189],"occurrence":[109],"determined":[111],"from":[112],"comprehensive":[113],"case":[114],"notes.":[115],"No":[116],"significant":[117,164],"differences":[118],"(%)":[123],"observed":[125],"between:":[126],"(19.6%),":[128],"(18.0%),":[130],"control":[132],"(17.9%)":[133],"groups":[134],"(P":[135,149,157,174,193],">":[136],"0.7);":[137],"successful":[138,180],"outcome":[142],"groups,":[143],"methadone:":[144],"20.0%":[145],"19.2%,":[147],"respectively":[148,156],"1.0);":[151],"buprenorphine:":[152],"18.4%":[153],"20.0%,":[155],"1.0).":[159],"Also,":[160],"there":[161],"no":[163],"relationships":[165],"between":[166],"genotype":[169,200],"0.47).":[176],"However,":[177],"significantly":[183],"fewer":[184],"carriers":[187,192],"experienced":[188],"than":[190],"non-A(1)":[191],"0.04).":[195],"In":[196],"conclusion,":[197],"effects":[201],"did":[202],"affect":[204],"outcomes.":[208],"This":[209],"suggests":[210],"need":[212],"for":[213,234],"further":[215],"prospective":[216],"investigation":[217],"into":[218],"role":[220],"response":[230],"pharmacotherapies":[233],"dependence.":[236]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":48},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}